1. I World Health Organisation Expert Committee. Prevention of coronary heart disease,1982
2. Conference on the health effects of blood lipids: optimal distributions for populations;Wynder, E.L.; Blackburn, H.; Lewis, B.; Wissler, R.W.;Prev Med,1979
3. Cancer incidence by levels of cholesterol. J7AMA 1981; 245: 247-52. Committee of Principal Investigators. Report of a WHO cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol mortality: follow up. Lancet 1980; ii: 379-84. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease;Williams, R.R.; Sorlie, P.D.; McNamara, Feinleib M.; PM, Kannel; WB, Dawber; T.R.;JAMA,1975
4. ;ii:1090-5.
5. Cholesterol as a bioregulator in the development and;Inbar, M.; Shinitzky, M.,1974